Lunch Satellite Sessions

Full program will be published soon.

Pfizer Pharmaceuticals Israel | October 19

AI meets AF – A Revolution in AF Related Stroke Prevention.

Boehringer Ingelheim Israel LTD | October 19

The Cardio Metabolic Patient: New ESC & EASD Guidelines – What’s Good, What’s Missing, and How do We Implement?

Novartis Israel | October 19

Dilemmas in CV Risk Management.

Abbott Laboratories | October 19

How Soon Is Soon Enough for Structural Heart Treatment/Therapies/Intervention?

Bayer Israel | October 20

Thrombotic Management of Cardiovascular Diseases- What is New?

AstraZeneca (Israel) | October 20

New Era in the Heart Failure Treatment.

Novo Nordisk | October 20

ESC Diabetes and CVD Guideline: ‘Unprecedented’ New Evidence.

Medison Pharma | October 20

Edoxaban- Developed with the Elderly in Mind for AF.